FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Brian Andrews

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Activities & Behaviors

Questionnaires

Anatomy

Skin

Co-author Network

Publications

TOP 3
Dinesh Khanna; Daniel E Furst; Ron Hays; Grace S Park; Weng Kee Wong; James R Seibold; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Philip J Clements
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.
Philip J Clements; James R Seibold; Daniel E Furst; MD Mayes; Barbara A White; Fredrick M Wigley; Michael D Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Weng Kee Wong
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.
Paul J DeMarco; Michael H Weisman; James R Seibold; Daniel E Furst; Weng Kee Wong; Eric L Hurwitz; MD Mayes; Barbara A White; Fredrick M Wigley; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Philip J Clements
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Brian Andrews (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Dinesh Khanna; Daniel E Furst; Ron Hays; Grace S Park; Weng Kee Wong; James R Seibold; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Philip J Clements
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.
Annals of the rheumatic diseases 2006;65(10):1325-9.
2004: Philip J Clements; James R Seibold; Daniel E Furst; MD Mayes; Barbara A White; Fredrick M Wigley; Michael D Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Weng Kee Wong
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.
Seminars in arthritis and rheumatism 2004;33(4):249-63.
2002: Paul J DeMarco; Michael H Weisman; James R Seibold; Daniel E Furst; Weng Kee Wong; Eric L Hurwitz; MD Mayes; Barbara A White; Fredrick M Wigley; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Philip J Clements
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
Arthritis and rheumatism 2002;46(11):2983-9.
2001: Philip J Clements; Weng Kee Wong; Eric L Hurwitz; Daniel E Furst; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; James R Seibold
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
Arthritis and rheumatism 2001;44(3):653-61.
2000: Philip J Clements; Eric L Hurwitz; Weng Kee Wong; James R Seibold; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Daniel E Furst
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
Arthritis and rheumatism 2000;43(11):2445-54.
1999: Philip J Clements; Weng Kee Wong; Eric L Hurwitz; Daniel E Furst; MD Mayes; Barbara A White; Fredrick M Wigley; Michael Weisman; Water Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; R Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; S Weiner; Brian Andrews; Micha Abeles; James R Seibold
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
Arthritis and rheumatism 1999;42(11):2372-80.
1999: Philip J Clements; Daniel E Furst; Weng Kee Wong; MD Mayes; Barbara A White; Fredrick M Wigley; Michael H Weisman; Water Barr; L W Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; S Weiner; Brian Andrews; Micha Abeles; James R Seibold
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
Arthritis and rheumatism 1999;42(6):1194-203.